The Institute for Molecular Medicine Finland (FIMM) is an international research unit focusing on human genomics and personalised medicine at the Helsinki Institute of Life Science (HiLIFE) of the University of Helsinki - a leading Nordic university with a strong commitment to life science research. FIMM is part of the Nordic EMBL Partnership for Molecular Medicine, composed of the European Molecular Biology Laboratory (EMBL) and the centres for molecular medicine in Norway, Sweden and Denmark, and the EU-LIFE Community. A PhD student position is available in the research group of FIMM-EMBL Group Leader Dr. Esa Pitkänen at the Institute of Molecular Medicine Finland (FIMM), University of Helsinki. The research group will start at FIMM in July 2019, and will address data integration, analysis and interpretation challenges stemming from massive-scale data generated in clinical and research settings. We will work closely with interdisciplinary collaborators at University of Helsinki, Helsinki University Hospital, EMBL and German Cancer Research Center.
Apr-18-2019, 07:43:37 GMT